Evidence map›Paper›PMID 33907274›Full record

ArticleScientific reports2021

Inhibition of Wnt signalling by Notch via two distinct mechanisms.

Ahmet Acar, Ana Hidalgo-Sastre, Michael K Leverentz, Christopher G Mills, Simon Woodcock, Martin Baron, Giovanna M Collu, Keith Brennan

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Biparental inheritance of germline-specific chromosomes in the sea lamprey and their roles in oocytes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Breast Morphogenesis: From Normal Development to Cancer.Advances in experimental medicine and biology · 2025
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Ahmet Acar *Department of Biological Sciences, Middle East Technical University, Universiteler Mah. Dumlupınar Bulvarı 1, 06800, Çankaya, Ankara, Turkey. acara@metu.edu.tr.
Ana Hidalgo-Sastre *Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.
Michael K LeverentzFaculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.
Christopher G MillsFaculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.
Simon WoodcockFaculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.
Martin BaronFaculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.
Giovanna M ColluDepartment of Developmental and Regenerative Biology, Icahn School of Medicine At Mount Sinai, One Gustave L. Levy Place, Box 1020, New York, NY, 10029, USA.
Keith BrennanFaculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester, M13 9PT, UK. keith.brennan@manchester.ac.uk.
University of Manchester · GBManchester Academic Health Science Centre · GBIcahn School of Medicine at Mount Sinai · USMiddle East Technical University · TR

Funding

Biotechnology and Biological Sciences Research Council BB/C503162/1Biotechnology and Biological Sciences Research Council BB/E002285/1Biotechnology and Biological Sciences Research Council BB/H000976/1Wellcome TrustWellcome Trust 085073/Z/08/ZWellcome Trust 65994
6 · The paper itself

Abstract

Notch and Wnt are two essential signalling pathways that help to shape animals during development and to sustain adult tissue homeostasis. Although they are often active at the same time within a tissue, they typically have opposing effects on cell fate decisions. In fact, crosstalk between the two pathways is important in generating the great diversity of cell types that we find in metazoans. Several different mechanisms have been proposed that allow Notch to limit Wnt signalling, driving a Notch-ON/Wnt-OFF state. Here we explore these different mechanisms in human cells and demonstrate two distinct mechanisms by which Notch itself, can limit the transcriptional activity of β-catenin. At the membrane, independently of DSL ligands, Notch1 can antagonise β-catenin activity through an endocytic mechanism that requires its interaction with Deltex and sequesters β-catenin into the membrane fraction. Within the nucleus, the intracellular domain of Notch1 can also limit β-catenin induced transcription through the formation of a complex that requires its interaction with RBPjκ. We believe these mechanisms contribute to the robustness of cell-fate decisions by sharpening the distinction between opposing Notch/Wnt responses.

Indexed as

Wnt Signaling Pathwaybeta CateninCell NucleusHCT116 CellsHEK293 CellsHumansImmunoglobulin J Recombination Signal Sequence-Binding Proteinrab5 GTP-Binding ProteinsReceptor, Notch1Receptors, NotchTranscription, Geneticbeta CateninCTNNB1 protein, humanImmunoglobulin J Recombination Signal Sequence-Binding ProteinNOTCH1 protein, humanRAB5C protein, humanrab5 GTP-Binding ProteinsRBPJ protein, humanReceptor, Notch1Receptors, Notch

Identifiers

PMID33907274
PMCPMC8079408
OpenAlexW3159051203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.